Jamie L. Reynoso, CEO, Medicare Advantage at CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV), sold 60,770 shares at $3.58 ($218K) on 2025-11-04, disclosed to the SEC on 2025-11-05.
Scheduled sale ($218k) by CEO, Medicare Advantage under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.58 | 30,385 | $109K | 50.0% |
| 2 | $3.58 | 30,385 | $109K | 50.0% |
| Total | $3.58 avg | 60,770 | $218K | 100% |
| Filing → |
| CLOV | SELL | 2026-09-15 | $44K | — | Filing → |
| CLOV | SELL | 2026-07-17 | $22K | — | Filing → |
| CLOV | SELL | 2026-07-16 | $61K | — | Filing → |